Free tool
Drugs in development
Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations
Drugs in development
3,685
Not FDA-approved
In Phase 3
1,424
Highest phase reached
Matching your filters
3,685
3,685 drugs in development
Names, sponsors and conditions come from the trial records. Click a drug for its trials.
- VBC108Phase 21 trial
VelaVigo Bio Inc · Advanced Solid Tumors
- VBC117Phase 21 trial
VelaVigo Bio Inc · Advanced Solid Tumors
- VCA-894APhase 21 trial
Vanda Pharmaceuticals · Charcot Marie Tooth Disease (CMT), Neuromuscular Diseases (NMD)
- VDMN-21Phase 21 trial
Veradermics, Inc. · Verruca Vulgaris, Warts, Common Wart
- Vebeglogene autotemcelBeta-globin lentiviral vector transduced autologous HSPCsPhase 21 trial
Lantu Biopharma · Beta-Thalassemia
- VEL-101Pegrizeprument, FR104Phase 21 trial
Asahi Kasei Therapeutics, Inc. · Transplantation, Kidney
- VERT-002PFL-002Phase 21 trial
Pierre Fabre Medicament · Solid Tumor, MET Alteration
- VERVE-102LY4636581Phase 21 trial
Eli Lilly · Atherosclerosis, Cardiovascular Disease, Hypercholesterolemia
- VG712A-dmDT390-bisFv fusion protein, UCHT1Phase 21 trial
Virogen Biotechnology Inc. · Mycosis Fungoides
- VG801Phase 21 trial
VeonGen Therapeutics GmbH · Retinal Dystrophy Due to Biallelic ABCA4 Mutations, Stargardt Disease 1
- VH3810109Phase 21 trial
GSK · HIV Infections
- VH4011499Phase 21 trial
GSK · HIV Infections
- VH4524184Phase 21 trial
GSK · HIV Infections
- VI-0609Phase 21 trial
VIVUS LLC · Lymphoma, Non-Hodgkin Lymphoma, Hodgkin Lymphoma
- VIB305Phase 21 trial
Vibrant Sciences Limited · Advanced Solid Tumors
- VipoglanstatPhase 21 trial
Gesynta Pharma AB · Endometriosis
- VIR-5818Phase 21 trial
Vir Biotechnology, Inc. · Locally Advanced or Metastatic HER2-Expressing Cancers
- VLS-1488Phase 21 trial
Volastra Therapeutics, Inc. · Advanced Solid Tumor, High Grade Serous Adenocarcinoma of Ovary, Squamous Non-small-cell Lung Cancer
- VMD-102Single agentPhase 21 trial
VM Discovery, Inc. · Hepatocellular Carcinoma (HCC), Metastatic Uveal Melanoma, Renal Cell Carcinoma (RCC)
- VMD-3866Phase 21 trial
VM Therapeutics LLC · Chemotherapy-induced Peripheral Neuropathy, Chemotherapy-induced Neuropathic Pain, CIPN - Chemotherapy-Induced Peripheral Neuropathy
- VMD-928Phase 21 trial
VM Oncology, LLC · Head and Neck Carcinoma, Adenoid Cystic Carcinoma, Lung Cancer
- VO659Phase 21 trial
Vico Therapeutics B. V. · Spinocerebellar Ataxia Type 1, Spinocerebellar Ataxia Type 3, Huntington Disease
- vopimetostatPhase 21 trial
Tango Therapeutics, Inc. · PDAC, PDAC - Pancreatic Ductal Adenocarcinoma, NSCLC
- VOY-101Phase 21 trial
Perceive Biotherapeutics, Inc. · Age-Related Macular Degeneration, Geographic Atrophy, Non-neovascular AMD
- VP-001Phase 21 trial
PYC Therapeutics · Retinitis Pigmentosa 11, Retinal Degeneration, Retinal Disease
- VP-16Phase 21 trial
Sichuan Honghe Biotechnology Co., Ltd. · Recurrent Glioblastoma
- VRN110755Phase 21 trial
Voronoi, Inc · EGFR-Mutant Non-Small Cell Lung Cancer
- VS-101Phase 21 trial
VSPharmTech Co.,Ltd. · Head and Neck Cancer Squamous Cell Carcinoma
- VSA006Phase 21 trial
Visirna Therapeutics HK Limited · Nash
- VSJ-110Phase 21 trial
Vanda Pharmaceuticals · Dry Eye
- VT7208Phase 21 trial
Vidya Therapeutics Inc · Multiple Sclerosis
- VTRU200Phase 21 trial
Vitruviae · Acute Myeloid Leukemia, Diffuse Large B Cell Lymphoma (DLBCL), High Risk Myelodysplastic Syndrome
- VTX2735LY5625574Phase 21 trial
Zomagen Biosciences Ltd. · Recurrent Pericarditis
- VUM02Phase 21 trial
Wuhan Optics Valley Vcanbiopharma Co., Ltd. · Steroid-refractory Acute Graft-versus-host Disease
- VV119Phase 21 trial
Vigonvita Life Sciences · Schizophrenia
- VV913Phase 21 trial
Vigonvita Life Sciences · Premature Ejaculation
- VVD-133214Phase 21 trial
Vividion Therapeutics, Inc. · Colorectal Adenocarcinoma
- VX-01Phase 21 trial
Vantage Biosciences Ltd · Diabetic Retinopathy, NPDR - Non Proliferative Diabetic Retinopathy
- VX-264Phase 21 trial
Vertex Pharmaceuticals · Type 1 Diabetes
- VX-407Phase 21 trial
Vertex Pharmaceuticals · Autosomal Dominant Polycystic Kidney Disease (ADPKD)
- VY7523Phase 21 trial
Voyager Therapeutics · Alzheimer's Disease (AD)
- WAL0921Phase 21 trial
Walden Biosciences · Diabetic Nephropathies, Primary Focal Segmental Glomerulosclerosis, Minimal Change Disease
- WAS123Phase 21 trial
EMS · Schizophenia Disorder
- WEF-001Phase 21 trial
Auricula Biosciences Inc. · Advanced or Metastatic KRAS-mutant Tumor in Pancreatic Adenocarcinoma, Advanced or Metastatic KRAS-mutant Tumor in Colorectal Cancer, Advanced or Metastatic KRAS-mutant Tumor in Non Small Cell Lung Cancer
- WJ22096Phase 21 trial
Nanjing Jingao biomidical technology Co. Ltd. · Advanced Solid Tumors
- WTX-330Phase 21 trial
Werewolf Therapeutics, Inc. · Advanced or Metastatic Solid Tumors, Non-Hodgkin Lymphoma
- WVE-006Phase 21 trial
Wave Life Sciences USA, Inc. · Alpha-1 Antitrypsin Deficiency
- WVE-007Phase 21 trial
Wave Life Sciences USA, Inc. · Overweight and Obesity
- WXSH0102Phase 21 trial
Cisen Pharmaceutical CO., LTD. · Vaginitis
- XC001Phase 21 trial
XyloCor Therapeutics, Inc. · Coronary Artery Disease (CAD)
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.